December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

247.87 +5.98 (+2.47%)
Streaming Delayed Price Updated: 2:02 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
News headline image
What 8 Analyst Ratings Have To Say About Insulet ↗
 
Via Benzinga
News headline image
Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)
From Insulet Corporation
Via Business Wire
News headline image
Where to Invest $5,000 for the Next 20 Years ↗
These are high-growth opportunities investors should focus on for the long haul. 
Via The Motley Fool
News headline image
Just 8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens ↗
This elite eight meet long-term growth criteria for sales and earnings. 
Via Investor's Business Daily
News headline image
Expert Ratings for Insulet ↗
 
Via Benzinga
News headline image
Insulet Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Recap: Insulet Q1 Earnings ↗
 
Via Benzinga
News headline image
Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
From Insulet Corporation
Via Business Wire
News headline image
Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers ↗
 
Via Benzinga
News headline image
Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific Sessions
From Insulet Corporation
Via Business Wire
News headline image
4 Analysts Have This to Say About Insulet ↗
 
Via Benzinga
News headline image
Analyst Expectations for Insulet's Future ↗
 
Via Benzinga
News headline image
Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom
From Insulet Corporation
Via Business Wire
News headline image
Medtronic's EOflow Acquisition Will Not Impact Insulet's Omnipod' Insulin Pump In Near or Medium Term: Analyst ↗
 
Via Benzinga
News headline image
AMD Stock, AI Play And New S&P 500 Member Lead 5 Stocks Near Buy Points ↗
AMD and a new S&P 500 member lead this weekend's watch list. 
Via Investor's Business Daily
News headline image
Insulet Reports Better-Than-Expected Q1 Earnings As Omnipod 5 Launch Gains Momentum, Lifts Guidance ↗
  
Via Benzinga
News headline image
Insulet Announces New Organizational Structure to Drive Further Growth
From Insulet Corporation
Via Business Wire
News headline image
Preview: Insulet's Earnings ↗
 
Via Benzinga
News headline image
Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)
From Insulet Corporation
Via Business Wire
News headline image
Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment
From Insulet Corporation
Via Business Wire
News headline image
Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes
From Insulet Corporation
Via Business Wire
News headline image
5 S&P 500 Stocks Showing Strength As Recession Fears Rise ↗
Medical stocks are holding up amid economic and market uncertainty. 
Via Investor's Business Daily
News headline image
Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023
From Insulet Corporation
Via Business Wire
News headline image
CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)
From Insulet Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 23, 2023 ↗
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
From Insulet Corporation
Via Business Wire
News headline image
3 Growth Stocks That Have Delivered 10X Returns Over the Past Decade ↗
Are these stocks still good buys today? 
Via The Motley Fool
News headline image
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.